|
인쇄하기
취소
|
Korea Kolmar Received KFDA Approvals on Bioequivalence for Its Generics
Published: 2004-12-22 06:57:00
Updated: 2004-12-22 06:57:00
Korea Kolmar, a domestic company specialized in cosmetics contract manufacturing, has recently received approvals from the Korea Food and Drug Administration (KFDA) for pharmaceutical bioequivalence on its three generic products containing active ingredients of glimepiride, meloxicam, and loxoprofen sodium.
The subject approvals indicate Korea Kolmar’s capabilities in its pharmaceutical rela...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.